Nephrectomies At Tobruk Medical Center

• Adnan S. Ben Khayal

  Urology Department, Faculty of Medicine, Tobruk University, Tobruk, Libya

  Author

• Ghareeb M. Ghareeb

  Urology Department, Faculty of Medicine, Tobruk University, Tobruk, Libya

  Author

Background. Nephrectomy is used both to treat renal cell carcinoma (RCC) and to remove kidneys destroyed by benign disease. The balance between these indications reflects local epidemiology and access to care. Aim. To appraise the retrospective series of nephrectomies at Tobruk Medical Centre reported by Ben Khayal and Ghareeb (2026) against recent international evidence. Findings. Of 45 tabulated patients, 71.1% were older than 45 years, 53.3% were male, 60.0% had left-sided surgery, and 46.7% (21/45) had malignant disease. Malignancy accounted for 23.1% of operations in patients younger than 45 years and 56.3% in older patients. The predominance of non-malignant indications contrasts with historical European series and may reflect stone- and infection-related kidney loss, as well as the centre's referral role. Conclusions. The series is a useful first descriptive baseline. Histology, procedure type, surgical approach, complications, and follow-up should be added before it can guide practice, and hereditary RCC assessment should be considered for young patients with malignancy.

1. Adnan S. Ben Khayal, Urology Department, Faculty of Medicine, Tobruk University, Tobruk, Libya

   Urology Department, Faculty of Medicine, Tobruk University, Tobruk, Libya

2. Ghareeb M. Ghareeb, Urology Department, Faculty of Medicine, Tobruk University, Tobruk, Libya

   Urology Department, Faculty of Medicine, Tobruk University, Tobruk, Libya

Beisland, C., Medby, P. C., Sander, S., & Beisland, H. O. (2000). Nephrectomy – indications, complications and postoperative mortality in 646 consecutive patients. European Urology, 37(1), 58–64. https://doi.org/10.1159/000020101 DOI: https://doi.org/10.1159/000020101

Ben Khayal, A. S., & Ghareeb, G. M. (2026). Nephrectomies at Tobruk Medical Center [Manuscript submitted for publication to the Derna Academy Journal for Applied Sciences]. Faculty of Medicine, Tobruk University.

Bex, A., Ghanem, Y. A., Albiges, L., Bonn, S., Campi, R., Capitanio, U., Dabestani, S., Hora, M., Klatte, T., Kuusk, T., Lund, L., Marconi, L., Palumbo, C., Pignot, G., Powles, T., Schouten, N., Tran, M., Volpe, A., & Bedke, J. (2025). European Association of Urology guidelines on renal cell carcinoma: The 2025 update. European Urology, 87(6), 683–696. https://doi.org/10.1016/j.eururo.2025.02.020 DOI: https://doi.org/10.1016/j.eururo.2025.02.020

Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., Kassouf, W., Mitchell, T., Montironi, R., O’Brien, T., Panebianco, V., Scelo, G., Shuch, B., van Poppel, H., Blosser, C. D., & Psutka, S. P. (2022). Epidemiology of renal cell carcinoma: 2022 update. European Urology, 82(5), 529–542. https://doi.org/10.1016/j.eururo.2022.08.019 DOI: https://doi.org/10.1016/j.eururo.2022.08.019

Chiancone, F., Persico, F., Fabiano, M., Meccariello, C., Giannella, R., Fedelini, M., Lughezzani, G., & Fedelini, P. (2023). Comparison of laparoscopic versus open simple nephrectomy in patients with xanthogranulomatous pyelonephritis: A single-center analysis of outcomes and predictors of surgical approaches and complications. Current Urology, 17(2), 135–140. https://doi.org/10.1097/CU9.0000000000000067 DOI: https://doi.org/10.1097/CU9.0000000000000067

Ismail, F., Elsayed, A. G., El-Garawani, I., & Abdelsameea, E. (2021). Cancer incidence in the Tobruk area, eastern Libya: First results from Tobruk Medical Centre. Epidemiology and Health, 43, Article e2021050. https://doi.org/10.4178/epih.e2021050 DOI: https://doi.org/10.4178/epih.e2021050

Kim, J. H., Shim, S. R., Lee, H. Y., Park, J. J., Khandwala, Y., Jeong, I. G., & Chung, B. I. (2020). Prevalence of benign pathology after partial nephrectomy for suspected renal tumor: A systematic review and meta-analysis. International Journal of Surgery, 84, 161–170. https://doi.org/10.1016/j.ijsu.2020.11.009 DOI: https://doi.org/10.1016/j.ijsu.2020.11.009

Larcher, A., Campi, R., Bex, A., Bray, F., Bukavina, L., Jonasch, E., Jemal, A., Linehan, W. M., Marandino, L., Mir, M. C., Mollica, V., Shuch, B., Stewart, G. D., Sung, H., Tran, M., & Kutikov, A. (2025). Epidemiology of renal cancer: Incidence, mortality, survival, genetic predisposition, and risk factors. European Urology, 88(4), 341–358. https://doi.org/10.1016/j.eururo.2025.06.005 DOI: https://doi.org/10.1016/j.eururo.2025.06.005

• PDF

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.